I was tempted by “Gene-Mapping Initiative Takes Aim at Disease,” Wall Street Journal, January 31, 2015 A3, dealing with the government’s proposal to gather and study a collection of genetic data on a bunch of its citizens. Pay no attention to the article the other day about what you can learn from anonymized information.
I also looked closely at “Debate Heightens Over Measuring Health-Care Quality,” Wall Street Journal, January 31, 2015 A3, which discusses, briefly, possible metrics to measure the quality, versus the quantity, of medical care. And metrics are a part of analytics.
But I decided to go with “Pom’s Ads Misled Consumers, Court Says,” Wall Street Journal, January 31, 2015 B3. The FTC pops a company for implying health benefits from drinking its pomegranate-flavored juice. One documented trial establishing the health benefits would be enough. Commercial speech can’t be deceptive.
Are deceptive ad claims within the ambit of information governance?